Covered recipient · General Payments record
DANIELE NICHOLE JOHNSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$305.46
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.46 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $102.04 | 5 |
| Lilly USA, LLC | $41.65 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.90 | 2 |
| Astellas Pharma US Inc | $35.85 | 2 |
| Amgen Inc. | $33.96 | 2 |
| Novo Nordisk AS | $20.69 | 1 |
| Gilead Sciences, Inc. | $17.79 | 1 |
| GlaxoSmithKline, LLC. | $15.58 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $305.46 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.28 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107409043 | CMS |
| ABBVIE INC. | $19.91 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107409045 | CMS |
| ABBVIE INC. | $18.14 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107409047 | CMS |
| ABBVIE INC. | $24.47 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107409049 | CMS |
| ABBVIE INC. | $20.24 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107409051 | CMS |
| Amgen Inc. | $14.41 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115768686 | CMS |
| Amgen Inc. | $19.55 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115768697 | CMS |
| Astellas Pharma US Inc | $18.00 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139478982 | CMS |
| Astellas Pharma US Inc | $17.85 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139496846 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.72 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118028882 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.18 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118028884 | CMS |
| Gilead Sciences, Inc. | $17.79 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133671698 | CMS |
| GlaxoSmithKline, LLC. | $15.58 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115913273 | CMS |
| Lilly USA, LLC | $20.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608239 | CMS |
| Lilly USA, LLC | $20.83 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135562812 | CMS |
| Novo Nordisk Inc | $20.69 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100564488 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.